Literature DB >> 14044501

[CLINICAL AND ANATOMOPATHOLOGICAL STUDIES ON COMBINED FORMS OF PRESENILE BRAIN ATROPHY (PICK, ALZHEIMER) WITH ATROPHYING SPINAL PROCESSES].

W POPPE, A TENNSTEDT.   

Abstract

Entities:  

Keywords:  AMYOTROPHIC LATERAL SCLEROSIS; MUSCULAR ATROPHY; PSYCHOSES, PRESENILE; SPINAL CORD

Mesh:

Year:  1963        PMID: 14044501

Source DB:  PubMed          Journal:  Psychiatr Neurol (Basel)        ISSN: 0370-1956


× No keyword cloud information.
  8 in total

1.  Selective loss of nigral neurons in Pick's disease: a morphometric study.

Authors:  T Uchihara; K Tsuchiya; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  [Clinical and pathological findings in the syndrome amyotrophy-parkinsonism-dementia (author's transl)].

Authors:  H Kaiya; P Mehraein
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-06-08

3.  Cerebral lesions in familial amyotrophic lateral sclerosis and dementia.

Authors:  M H Finlayson; J B Martin
Journal:  Acta Neuropathol       Date:  1973-11-05       Impact factor: 17.088

4.  [Combination of amyotrophic lateral sclerosis with Pick's disease].

Authors:  M Minauf; K Jellinger
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1969

5.  [Clinical and anatomical aspects in cases of "pure" temporal lobe atrophy in pick's disease and the basal neocortex].

Authors:  H Jakob
Journal:  Dtsch Z Nervenheilkd       Date:  1969

6.  Progressive dementia with motor neuron disease. An additional case report and neuropathological review of 20 cases in Japan.

Authors:  Y Mitsuyama; H Kogoh; K Ata
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

7.  Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases.

Authors:  Y Mitsuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

8.  Motor neuron disease and frontotemporal dementia: One, two, or three diseases?

Authors:  Thomas H Bak
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.